Clinical trial
Randomised Controlled Trial of Two Different Cumulative Dosages of Roaccutane for Cystic Acne
NCT07228481 is registered in ClinicalTrials.gov with Premier Specialists, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Trial of Two Different Cumulative Dosages of Roaccutane for Cystic Acne
- Lead sponsor
- Premier Specialists, Australia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 26, 2001
- Completion date
- May 10, 2025
- Enrollment
- 91 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acne cystic